Despite major advances in treatment and prevention, ending the HIV epidemic remains a global priority requiring continued innovation and effective delivery strategies. Emerging technology and its application are creating opportunities to improve outcomes and pursue durable remission or cure. 

This Keystone Symposia conference on Ending HIV: At the Crossroads of Innovation and Delivery will feature the basic science of immunogen and monoclonal antibody design, product delivery technologies, and HIV remission strategies as well as breaking preclinical and clinical data. Attendees will gain insights into how new computational and delivery platform technologies can elevate the performance of infectious disease countermeasures. The meeting will also highlight novel approaches to HIV cure and reservoir assessment. 

The conference will bring together scientists, clinicians, public health experts, and global health organizations to foster collaboration across research and implementation. Joint programming with the Keystone Symposia conference on Vaccinology: Next-Generation Advances in Transforming Immunity further enhances this integration. 

The meeting will include research from resource-constrained and resource-rich settings as well as encompass perspectives from research scientists to the communities being served. The meeting is uniquely designed to engender frank strategic discussion and facilitate new and renewed collaborations to address challenges and develop strategies to prevent and cure HIV amidst an evolving scientific landscape.